EADV Podcast

E46: The Role Of Autoantibodies In Itchy And Blistering Diseases

Could better understanding of the role of autoantibodies hold the key to personalised treatments in itchy and blistering diseases?
 
This week we bring together experts Prof. Kridin and Dr. Meijer to discuss their recent JEADV publications concerning the role of autoantibodies in itchy and blistering diseases. Prof. Kridin talks about the pathophysiology and therapeutic approaches to treat patients with bullous pemphigoid and comorbid psoriasis, followed by Dr. Meijer’s explanation regarding the role of IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients.
 
Referenceshttps://onlinelibrary.wiley.com/doi/10.1111/jdv.17013
https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16996
 
Not an EADV Member? Click Here for more information on the advantages and opportunites that only EADV Members have.

E45: Cosmetic Dermatology: Challenging Situations Part 1

Should you stop an anticoagulant for thrombosis to prevent bruising after cosmetic procedures? What changed during the pandemic? Can ablative laser plumes harm operating room personnel?
This week Prof. Ashraf Badawi discusses challenging situations that can arise in cosmetic dermatology. He brings practical clinical experience as well as the current research to the discussion.
 
Not an EADV Member? Click Here for more information on the advantages and opportunities that only EADV Members have- including access to webcasts such as this one.

E44: Editor’s Picks November 2021

Join us as we go through the JEADV Editor's Picks of November 2021:(1) Long-term safety data for a monoclonal antibody used in psoriasis(2) Preventing anaphylactoid symptoms following Covid-19 vaccination(3) Innovative surgery option for bromhidrosis (4) Surprising trends in syphilis
Read the editor's picks here:
https://onlinelibrary.wiley.com/doi/10.1111/jdv.17691

E43: The Evolving Field of Dermato-oncology: A License to Examine

This week EADV Advocacy Working Group Leader Myrto Trakatelli talks with Stella Siskou about topics including EPIDERM, the EADV Advocacy Working Group, and a position paper on the role of dermatologists in the evolving field of Dermato-oncology.
 
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Forcehttps://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16849
 

E42: Changing Treatment Landscape in Psoriasis

This week Dr. Mark Lebwohl from Icahn School of Medicine at Mount Sinai joins us to discuss the latest treatment options for psoriasis and his research focusing on new topical therapies for the management of the disease.
 
Links to the six articles discussed can be found here:
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial
Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52-week results from a double-blind phase 3b trial (CLARITY)
Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER-3 study
Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion inmoderate-to-severe plaque psoriasis: phase 3 open-label study
Itch: an under-recognized problem in psoriasis

E41: Editor‘s Picks October 2021

Join us as we go through the JEADV Editor's Picks of October 2021:
(1) Are skin types equally represented in Scandinavian dermatology textbooks?
(2) Apremilast for palmoplantar pustulosis under study
(3) The link between autoimmune bullous diseases and neurological diseases
(4) Investigating the cancer risk of using a biologic drug in atopic dermatitis
Read the editor's picks here:
https://onlinelibrary.wiley.com/doi/10.1111/jdv.17616

E40: Pemphigus Vulgaris and Foliaceus: Latest management advancements

This week esteemed Professor Branka Marinović shares her experience as Secretary General of the EADV (2017-2021) and reflects on some significant ways how the Academy has changed in the past years. Join us as Prof. Marinovic talks about how the “Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus” facilitated the everyday work of Dermatologists and improved quality of care. Finally, the importance of collaboration between the Autoimmune Blistering Diseases Task Force of the EADV and patient organizations is also highlighted.
 
The guidelines can be read here: Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the EADV

E39: Life on the Ocean Wave: Success of a targeted skin cancer screening programme

This month we discuss a recent publication reporting on the success of a targeted skin cancer screening initiative at a sailing festival with author Professor Khosrotehrani, a clinician-scientist and dermatologist at the University of Queensland, and the Diamantina Institute, Brisbane. Listen as moderator Dr Sarah Walsh explores the challenges and implications of delivering such a screening programme in the unique location of Hamilton Island, off the coast of Queensland.
 
Read all about this interesting subject here:
https://onlinelibrary.wiley.com/doi/10.1111/jdv.17062
 
💡Did you know that a subscription to the high-impact factor JEADV is included in the EADV Membership?